Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Pharmamol is a specialized biotechnology company based in Italy that focuses on computational drug discovery and molecular modeling services. The company provides advanced in silico solutions to pharmaceutical and biotech partners, including virtual screening, lead optimization, and ADME-Tox prediction. By leveraging high-performance computing and proprietary algorithms, Pharmamol aims to accelerate the early stages of drug development and improve the success rate of small molecule candidates. Their expertise spans across various therapeutic areas, supporting the design of novel chemical entities with optimized pharmacological profiles.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on PharmaMol.